"PUER (Previously Unrecognized Emerging Risks) Life Clinical Study"

Enrolling by invitationOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

March 27, 2023

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2030

Conditions
Aging
Interventions
DIAGNOSTIC_TEST

Measurements Only

This is an observational study only using biospecimen and imaging-based measurements only

Trial Locations (1)

30350

Puer Research, LLC, Atlanta

All Listed Sponsors
lead

Puer Research, LLC

NETWORK